NCT07085611View on ClinicalTrials.gov

Neutralizing Power of Serum Antibodies - 2

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 22, 2025

Primary Completion Date

July 11, 2030

Study Completion Date

July 11, 2035

Conditions
COVID-19SARS-CoV-2 ViraemiaMonkey PoxVaccinationSerumMucosal Immunity
Interventions
OTHER

Sample collection (blood and optional nasal swab)

Venous blood collection (2 tubes of 6 mL) and optional nasal swab at each visit. Aliquots analyzed for neutralizing activity against SARS-CoV-2 and MPXV using validated assays at Institut Pasteur

Trial Locations (1)

45067

RECRUITING

CHU Orléans, Orléans

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT07085611 - Neutralizing Power of Serum Antibodies - 2 | Biotech Hunter | Biotech Hunter